Dr. Kuriakose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Henry Ford Health System
2799 W.Grand Blvd
Detroit, MI 48202Phone+1 313-916-3788
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1999 - 2002
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1996 - 1999
- Christian Medical College LudhianaClass of 1990
Certifications & Licensure
- MI State Medical License 1996 - 2027
- FL State Medical License 1998 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2008-2013
- Join now to see all
Clinical Trials
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice Start of enrollment: 2016 Dec 14
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsThe long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges.M. Joseph John, Philip Kuriakose, Mark Smith, Eve Roman, Sudhir Tauro
Blood Cancer Journal. 2021-08-06 - 39 citationsA cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L. Sood, Dunlei Cheng, Margaret V. Ragni, Craig M. Kessler, Doris Quon
Blood Advances. 2014-12-06 - 47 citationsChanges in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.Johnny Mahlangu, K. N. Weldingh, Steven R. Lentz, Shipra Kaicker, Faraizah Abdul Karim
Journal of Thrombosis and Haemostasis. 2015-11-01
Abstracts/Posters
- Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database AnalysisPhilip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospecti...Philip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialPhilip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: